↓ Skip to main content

Cefepime Dosing in the Morbidly Obese Patient Population

Overview of attention for article published in Obesity Surgery, January 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
29 Mendeley
Title
Cefepime Dosing in the Morbidly Obese Patient Population
Published in
Obesity Surgery, January 2012
DOI 10.1007/s11695-011-0586-8
Pubmed ID
Authors

Barrie S. Rich, Rebecca Keel, Vanessa P. Ho, Harma Turbendian, Cheguevara I. Afaneh, Gregory F. Dakin, Alfons Pomp, David P. Nicolau, Philip S. Barie

Abstract

Proper dosing of specific antibiotics in morbidly obese patients has been studied inadequately. However, these data are beneficial as this patient population is at an increased risk to develop postoperative infections. Cefepime is an antibiotic used for the treatment of both gram-positive and especially gram-negative infections; administration of the appropriate dose in the morbidly obese population is crucial. We therefore examined the pharmacokinetics of cefepime in patients with body mass index >40 kg/m(2). Ten morbidly obese patients, with a mean [±SD] estimated glomerular filtration rate of 108.4 ± 34.6 mL/min, undergoing elective weight loss surgical procedures were administered cefepime in addition to standard prophylactic cefazolin and studied. Serial serum cefepime concentrations were analyzed after dosing using a validated high performance liquid chromatography method. Pharmacokinetics and duration above the minimum inhibitory concentration (MIC) were determined using a protein binding value of 15% and a MIC threshold of 8 μg/mL. Mean free cefepime concentrations for t = 30, 120, and 360 min were 69.6, 31.6, and 9.2 μg/mL, respectively. The dosing interval was calculated to maintain the free concentration above the MIC (fT > MIC) for 60% of the interval. This was determined to be 10.12 h, including time for infusion. There was no toxicity. Based on this analysis, an increased dose of 2 g every 8 h is necessary to maintain an adequate fT > MIC throughout the dosing interval. Further studies are necessary to determine the efficacy of this regimen in the settings of active infections and critical illness.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status Count As %
Other 4 14%
Student > Ph. D. Student 4 14%
Student > Master 3 10%
Student > Postgraduate 3 10%
Researcher 3 10%
Other 6 21%
Unknown 6 21%
Readers by discipline Count As %
Medicine and Dentistry 10 34%
Pharmacology, Toxicology and Pharmaceutical Science 7 24%
Environmental Science 2 7%
Chemistry 2 7%
Agricultural and Biological Sciences 1 3%
Other 3 10%
Unknown 4 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 February 2012.
All research outputs
#18,303,566
of 22,661,413 outputs
Outputs from Obesity Surgery
#2,525
of 3,358 outputs
Outputs of similar age
#196,218
of 245,904 outputs
Outputs of similar age from Obesity Surgery
#22
of 37 outputs
Altmetric has tracked 22,661,413 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,358 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one is in the 10th percentile – i.e., 10% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 245,904 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.